Navigation Links
Telesso Technologies wins Popular Science Invention Award for its novel peripheral IV catheter
Date:5/13/2009

Telesso Technologies Limited (ASX: TEO), a global healthcare company, announced today the FDA-approved guide wire-assisted peripheral IV catheter it is developing with Vascular Pathways, Inc., has been honored with the Popular Science Invention Award.

"Telesso is pleased to receive another exciting external validation of this innovative device that may revolutionize peripheral IV placement," said Telesso's CEO Nelson K. Stacks. "Attempts to start an IV frequently fail, which is frustrating for clinicians, painful for patients and costly to the health care system. The new guide-wire assisted peripheral IV catheter uses a practical design to improve the ability for clinicians to get it right the first time, creating efficiency, enhancing safety, reducing costs, and avoiding the need for re-sticks."

A post-market trial is currently comparing patients treated with Telesso's catheter to the industry's gold standard device for peripheral IV placement. Data review is expected in Q2-Q3 2009.

About the Guide Wire-Assisted Peripheral IV Catheter

A peripheral vein is the most common site for insertion of a catheter for short-term diagnostic or therapeutic use. The catheter is placed into the peripheral vein in the arm and is typically passed up inside the vein to a length of 2-3 inches. Telesso's uniquely-designed guide wire-assisted peripheral IV catheter device uses a first-in-class retractable nitinol guide wire system that is believed to enable easier IV access, reduce common safety risks, significantly lessen patient pain and discomfort, and provide cost savings to facilities by lowering administrative costs associated with failed IV starts. Telesso believes this catheter device is the first clinically meaningful advancement in peripheral IV access since automatic needle retraction catheters and addresses significant unmet needs in peripheral intravenous access.


'/>"/>

Contact: Jeff Riley
riley@telesso.com
619-309-7661
Cytori Therapeutics
Source:Eurekalert

Page: 1

Related medicine news :

1. Telesso initiates post-market head-to-head peripheral IV catheter study
2. MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited
3. MedClean Technologies, Inc. Approved in New Jersey
4. The EntreTech Forum Presents ... PHOTONICS/OPTICS - Understanding the Latest Applications of Light-based Technologies in Medical, Consumer, Industrial, and Defense Sectors
5. Children's Hospital Boston Advances Cutting-Edge Technologies with its New Technology Development Fund
6. Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results
7. Steven H. Kane Appointed as President and Chief Executive Officer of Patient Safety Technologies, Inc.
8. Global Med Technologies(R), Inc. to Report First Quarter Financial Results on Friday, May 15, 2009
9. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
10. Greenway Medical Technologies PrimeSuite Solution Provides OB/GYN Physicians With Instant Access to Labor and Delivery Information at Point-of-Care
11. Top 10 Hospital Technologies: C-Suite Watch List for 2009 and Beyond; Exclusive Insight on Critical Capital Decisions in ECRI Institute White Paper Available for Free Download
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... Houston, TX (PRWEB) , ... July 24, 2017 , ... ... $1000 student scholarship will be awarded for the fall semester to a deserving student. ... SignatureCare Emergency Centers Spring 2017 scholarship was awarded to Mariana Castillo who is a ...
(Date:7/24/2017)... ... July 24, 2017 , ... Horizon Goodwill Industries, ... unique opportunity that helps high school girls succeed in STEM programs as well ... Horizon Goodwill will host over 20 high school girls at their corporate headquarters ...
(Date:7/24/2017)... ... July 24, 2017 , ... The International Essential Tremor Foundation (IETF) will host ... tremor (ET). The seminar will take place on Saturday, Aug. 26 at the Embassy ... program will run from 9 a.m. to 12 p.m., with check-in beginning at 8 ...
(Date:7/24/2017)... NY (PRWEB) , ... July 24, 2017 , ... ... series of media initiatives designed to promote awareness for Topricin’s revolutionary, natural, after-burn ... elements is one of the leading causes of long term skin conditions, including ...
(Date:7/24/2017)... ... July 24, 2017 , ... Puregraft, the global leader in ... of United States Patent Number 9,695,398 (the '398 patent) and South Korean Patent ... and '324 patents cover methods and systems for optimizing fat grafts for current ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... It should come as no surprise to anyone ... the midst of a crippling opioid epidemic. According to the ... of overdose deaths from opiate-based medications has quadrupled, Says, Dr. ... dead from 2001 to 2015". During this time, the prescription ... quadrupled, drawing a compelling link between prescription and eventual addiction. ...
(Date:7/13/2017)... ROCKVILLE, Md. , July 13, 2017  New York ... watchers of pharmaceutical markets should be aware of.  From new ... These trends are detailed in a recently completed study, ... following: 1.  Age-Driven ... years, we have been aware of the impact the growing ...
(Date:7/11/2017)... 11, 2017 Zymo Research Corp., also known as ,The Epigenetics ... biological aging in a precise manner using the myDNAge ™ test. ... a professor of human genetics and biostatistics at the David Geffen ... Health , Zymo Research,s proprietary DNAge ™ technology is used to ... ...
Breaking Medicine Technology: